173 related articles for article (PubMed ID: 37748738)
1. Immune evasion on the nanoscale: Small extracellular vesicles in pancreatic ductal adenocarcinoma immunity.
Fyfe J; Dye D; Razak NBA; Metharom P; Falasca M
Semin Cancer Biol; 2023 Nov; 96():36-47. PubMed ID: 37748738
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer.
Sarkar R; Xu Z; Perera CJ; Apte MV
Semin Cancer Biol; 2023 Aug; 93():114-122. PubMed ID: 37225047
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment.
Purushothaman A; Oliva-Ramírez J; Treekitkarnmongkol W; Sankaran D; Hurd MW; Putluri N; Maitra A; Haymaker C; Sen S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834100
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment.
Li Y; Zhao W; Wang Y; Wang H; Liu S
J Nanobiotechnology; 2022 May; 20(1):208. PubMed ID: 35501802
[TBL] [Abstract][Full Text] [Related]
5. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
Liu X; Tang R; Xu J; Tan Z; Liang C; Meng Q; Lei Y; Hua J; Zhang Y; Liu J; Zhang B; Wang W; Yu X; Shi S
Gut; 2023 Nov; 72(12):2329-2343. PubMed ID: 37541772
[TBL] [Abstract][Full Text] [Related]
6. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma.
Nesteruk K; Levink IJM; Dits NFJ; Cahen DL; Peppelenbosch MP; Bruno MJ; Fuhler GM
Clin Transl Gastroenterol; 2022 Feb; 13(3):e00465. PubMed ID: 35363220
[TBL] [Abstract][Full Text] [Related]
7. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
Guerreiro EM; Øvstebø R; Thiede B; Costea DE; Søland TM; Kanli Galtung H
PLoS One; 2020; 15(9):e0238591. PubMed ID: 32886718
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles in pancreatic cancer progression and therapies.
Chang CH; Pauklin S
Cell Death Dis; 2021 Oct; 12(11):973. PubMed ID: 34671031
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms.
Liu C; He D; Li L; Zhang S; Wang L; Fan Z; Wang Y
Pharmacol Res; 2022 Sep; 183():106364. PubMed ID: 35901939
[TBL] [Abstract][Full Text] [Related]
10. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T
Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081
[TBL] [Abstract][Full Text] [Related]
11. Protumorogenic Potential of Pancreatic Adenocarcinoma-Derived Extracellular Vesicles.
Baj-Krzyworzeka M; Mytar B; Weglarczyk K; Szatanek R; Kijowski J; Siedlar M
Folia Biol (Praha); 2020; 66(3):104-110. PubMed ID: 33069189
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
Kabacaoglu D; Ciecielski KJ; Ruess DA; Algül H
Front Immunol; 2018; 9():1878. PubMed ID: 30158932
[TBL] [Abstract][Full Text] [Related]
13. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
[TBL] [Abstract][Full Text] [Related]
14. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
Xu X; Bhandari K; Xu C; Morris K; Ding WQ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108374
[TBL] [Abstract][Full Text] [Related]
15. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
16. Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought.
Agostini A; Orlacchio A; Carbone C; Guerriero I
Front Immunol; 2022; 13():876291. PubMed ID: 35711414
[TBL] [Abstract][Full Text] [Related]
17. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
[TBL] [Abstract][Full Text] [Related]
18. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
19. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
[TBL] [Abstract][Full Text] [Related]
20. Self-Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer.
Pan J; Lai Y; Zhang S; Zhang H; Shan Y; Huang L; Wang F; Yu H; Xu L; Xu Z
Adv Mater; 2023 Nov; 35(47):e2305798. PubMed ID: 37716012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
